−0.080AUD
−7.75 MAUD
74.85 M
About INVEX THERAPEUTICS LTD
Sector
Industry
Headquarters
Subiaco
Website
Founded
2019
ISIN
AU0000048621
FIGI
BBG00PD615S3
Invex Therapeutics Ltd. is a biopharmaceutical company, which engages in the research and development of treatment for neurological conditions resulting from raised intracranial pressure. It focuses on understanding and defining the mechanisms that regulate pressure in the brain and aims to repurpose and reformulate an already approved drug, Exenatide. The company was founded by Jason Loveridge and Alexandra J. Sinclair on March 8, 2019 and is headquartered in Subiaco, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IXC is 0.085 AUD — it has decreased by 5.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange INVEX THERAPEUTICS LTD stocks are traded under the ticker IXC.
INVEX THERAPEUTICS LTD is going to release the next earnings report on Aug 15, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track INVEX THERAPEUTICS LTD financials in yearly and quarterly reports right on TradingView.
Like other stocks, IXC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INVEX THERAPEUTICS LTD stock right from TradingView charts — choose your broker and connect to your account.